CRISPR-Cas for genome editing: classification, mechanism, designing and applications

S Bhatia, SK Yadav - International Journal of Biological Macromolecules, 2023 - Elsevier
Clustered regularly interspersed short pallindromic repeats (CRISPR) and CRISPR
associated proteins (Cas) system (CRISPR-Cas) came into light as prokaryotic defence …

Animal models of arrhythmia: classic electrophysiology to genetically modified large animals

S Clauss, C Bleyer, D Schuettler, P Tomsits… - Nature Reviews …, 2019 - nature.com
Arrhythmias are common and contribute substantially to cardiovascular morbidity and
mortality. The underlying pathophysiology of arrhythmias is complex and remains …

Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications

Y Li, Z Glass, M Huang, ZY Chen, Q Xu - Biomaterials, 2020 - Elsevier
The recently developed CRISPR/Cas9 technology has revolutionized the genome
engineering field. Since 2016, increasing number of studies regarding CRISPR therapeutics …

Cardiac tissue engineering: state-of-the-art methods and outlook

AH Nguyen, P Marsh, L Schmiess-Heine… - Journal of biological …, 2019 - Springer
The purpose of this review is to assess the state-of-the-art fabrication methods, advances in
genome editing, and the use of machine learning to shape the prospective growth in cardiac …

Non-invasive electromechanical cell-based biosensors for improved investigation of 3D cardiac models

G Caluori, J Pribyl, M Pesl, S Jelinkova… - Biosensors and …, 2019 - Elsevier
Cardiomyocytes (CM) placed on microelectrode array (MEA) were simultaneously probed
with cantilever from atomic force microscope (AFM) system. This electric/nanomechanical …

CRISPR innovations in tissue engineering and gene editing

ZS Razavi, M Soltani, M Souri, AJ van Wijnen - Life Sciences, 2024 - Elsevier
The CRISPR/Cas9 system is a powerful tool for genome editing, utilizing the Cas9 nuclease
and programmable single guide RNA (sgRNA). However, the Cas9 nuclease activity can be …

Ablation of OCT4 function in cattle embryos by double electroporation of CRISPR-Cas for DNA and RNA targeting (CRISPR-DART)

JL Nix, GP Schettini, SL Speckhart, AD Ealy… - PNAS …, 2023 - academic.oup.com
CRISPR-Cas ribonucleoproteins (RNPs) are important tools for gene editing in
preimplantation embryos. However, the inefficient production of biallelic deletions in cattle …

Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing

C Aslan, NM Zolbanin, F Faraji, R Jafari - Molecular Biotechnology, 2023 - Springer
Gene mutation correction was challenging until the discovery of clustered regularly
interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) …

New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?

VM Olkkonen, J Sinisalo, M Jauhiainen - Atherosclerosis, 2018 - Elsevier
Remarkably good results have been achieved in the treatment of atherosclerotic
cardiovascular diseases (CVD) by using statin, ezetimibe, antihypertensive, antithrombotic …

Monocyte transmodulation: the next novel therapeutic approach in overcoming ischemic stroke?

J Park, JY Chang, JY Kim, JE Lee - Frontiers in neurology, 2020 - frontiersin.org
The immune response following neuroinflammation is a vital element of ischemic stroke
pathophysiology. After the onset of ischemic stroke, a specialized vasculature system that …